Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Prosocial effects of oxytocin in two mouse models of autism spectrum disorders.

Teng BL, Nonneman RJ, Agster KL, Nikolova VD, Davis TT, Riddick NV, Baker LK, Pedersen CA, Jarstfer MB, Moy SS.

Neuropharmacology. 2013 Sep;72:187-96. doi: 10.1016/j.neuropharm.2013.04.038. Epub 2013 May 3.

2.

Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism.

Moy SS, Riddick NV, Nikolova VD, Teng BL, Agster KL, Nonneman RJ, Young NB, Baker LK, Nadler JJ, Bodfish JW.

Behav Brain Res. 2014 Feb 1;259:200-14. doi: 10.1016/j.bbr.2013.10.052. Epub 2013 Nov 8.

3.

Reversal of social deficits by subchronic oxytocin in two autism mouse models.

Teng BL, Nikolova VD, Riddick NV, Agster KL, Crowley JJ, Baker LK, Koller BH, Pedersen CA, Jarstfer MB, Moy SS.

Neuropharmacology. 2016 Jun;105:61-71. doi: 10.1016/j.neuropharm.2015.12.025. Epub 2015 Dec 31.

4.

Novel object exploration in the C58/J mouse model of autistic-like behavior.

Blick MG, Puchalski BH, Bolanos VJ, Wolfe KM, Green MC, Ryan BC.

Behav Brain Res. 2015 Apr 1;282:54-60. doi: 10.1016/j.bbr.2014.12.030. Epub 2014 Dec 19.

PMID:
25532914
5.

Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain.

Ryan BC, Young NB, Crawley JN, Bodfish JW, Moy SS.

Behav Brain Res. 2010 Mar 17;208(1):178-88. doi: 10.1016/j.bbr.2009.11.031. Epub 2009 Nov 24.

6.

GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism.

Silverman JL, Pride MC, Hayes JE, Puhger KR, Butler-Struben HM, Baker S, Crawley JN.

Neuropsychopharmacology. 2015 Aug;40(9):2228-39. doi: 10.1038/npp.2015.66. Epub 2015 Mar 10.

7.

D-Cycloserine improves sociability in the BTBR T+ Itpr3tf/J mouse model of autism spectrum disorders with altered Ras/Raf/ERK1/2 signaling.

Burket JA, Benson AD, Tang AH, Deutsch SI.

Brain Res Bull. 2013 Jul;96:62-70. doi: 10.1016/j.brainresbull.2013.05.003. Epub 2013 May 15.

8.

Social approach and repetitive behavior in eleven inbred mouse strains.

Moy SS, Nadler JJ, Young NB, Nonneman RJ, Segall SK, Andrade GM, Crawley JN, Magnuson TR.

Behav Brain Res. 2008 Aug 5;191(1):118-29. doi: 10.1016/j.bbr.2008.03.015. Epub 2008 Mar 21.

9.

D-cycloserine improves sociability and spontaneous stereotypic behaviors in 4-week old mice.

Deutsch SI, Pepe GJ, Burket JA, Winebarger EE, Herndon AL, Benson AD.

Brain Res. 2012 Feb 23;1439:96-107. doi: 10.1016/j.brainres.2011.12.040. Epub 2011 Dec 29.

PMID:
22261249
10.

Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice: possible implications for the pharmacotherapy of autism spectrum disorders.

Burket JA, Herndon AL, Winebarger EE, Jacome LF, Deutsch SI.

Brain Res Bull. 2011 Oct 10;86(3-4):152-8. doi: 10.1016/j.brainresbull.2011.08.001. Epub 2011 Aug 5.

PMID:
21840381
11.

Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains.

Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, Barbaro JR, Wilson LM, Threadgill DW, Lauder JM, Magnuson TR, Crawley JN.

Behav Brain Res. 2007 Jan 10;176(1):4-20. Epub 2006 Sep 12.

12.

Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)/J mouse model of autism spectrum disorders.

Burket JA, Benson AD, Tang AH, Deutsch SI.

Brain Res Bull. 2014 Jan;100:70-5. doi: 10.1016/j.brainresbull.2013.11.005. Epub 2013 Dec 1.

13.

Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism.

Silverman JL, Smith DG, Rizzo SJ, Karras MN, Turner SM, Tolu SS, Bryce DK, Smith DL, Fonseca K, Ring RH, Crawley JN.

Sci Transl Med. 2012 Apr 25;4(131):131ra51. doi: 10.1126/scitranslmed.3003501.

14.

Long-term exposure to intranasal oxytocin in a mouse autism model.

Bales KL, Solomon M, Jacob S, Crawley JN, Silverman JL, Larke RH, Sahagun E, Puhger KR, Pride MC, Mendoza SP.

Transl Psychiatry. 2014 Nov 11;4:e480. doi: 10.1038/tp.2014.117.

15.

[Oxytocin in the treatment of the social deficits associated to autism spectrum disorders].

Cachafeiro-Espino C, Vale-Martínez AM.

Rev Neurol. 2015 Nov 1;61(9):421-8. Review. Spanish.

16.

Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism.

Karvat G, Kimchi T.

Neuropsychopharmacology. 2014 Mar;39(4):831-40. doi: 10.1038/npp.2013.274. Epub 2013 Oct 7.

17.

Effects of oxytocin on serotonin 1B agonist-induced autism-like behavior in mice.

Lawson SK, Gray AC, Woehrle NS.

Behav Brain Res. 2016 Nov 1;314:52-64. doi: 10.1016/j.bbr.2016.07.027. Epub 2016 Jul 18.

PMID:
27439030
18.

Absence of preference for social novelty and increased grooming in integrin β3 knockout mice: initial studies and future directions.

Carter MD, Shah CR, Muller CL, Crawley JN, Carneiro AM, Veenstra-VanderWeele J.

Autism Res. 2011 Feb;4(1):57-67. doi: 10.1002/aur.180. Epub 2011 Jan 19.

19.

Genetically inbred Balb/c mice differ from outbred Swiss Webster mice on discrete measures of sociability: relevance to a genetic mouse model of autism spectrum disorders.

Jacome LF, Burket JA, Herndon AL, Deutsch SI.

Autism Res. 2011 Dec;4(6):393-400. doi: 10.1002/aur.218. Epub 2011 Aug 31.

PMID:
21882363
20.

Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin.

Lee PR, Brady DL, Shapiro RA, Dorsa DM, Koenig JI.

Neuropsychopharmacology. 2005 Oct;30(10):1883-94.

Supplemental Content

Support Center